FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Medical Devices

FDA Clears Medical AI Imaging Software

FDA clears a Bracco Diagnostics and Subtle Medical 510(k) for their artificial intelligence-powered software AiMify for brain MRIs.

latest-news-card-1
Human Drugs

Novocures Optune Lua for Lung Cancer OKd

Novocure wins PMA approval for Optune Lua for concurrent use with PD-1/PD-L1 inhibitors or docetaxel for treating adult patients with metastatic non-s...

latest-news-card-1
Human Drugs

Court Tosses Novartis Entresto Suit Against FDA

The DC federal court rules in favor of FDA and MSN Pharmaceuticals as defendants in a suit filed by Novartis over the agencys approval of MSNs generic...

latest-news-card-1
Medical Devices

FDA on Curbing X-ray Device Interference

FDA makes recommendations to prevent damage to wearable medical devices from X-ray imaging, including CT scans.

latest-news-card-1
Human Drugs

CGMP Violations at Outin Futures

FDA warns Koreas Outin Futures Corp. about CGMP and misbranding violations at its drug manufacturing facility.

latest-news-card-1
Federal Register

Noxafil Not Withdrawn Over Safety/Efficacy

Federal Register notice: FDA determines that Merck Sharp & Dohmes Noxafil (posaconazole) 100g delayed-release tablets were not withdrawn from sale due...

latest-news-card-1
Federal Register

IntraBio Wins Priority Voucher for Aqneursa Approval

Federal Register notice: FDA issues IntraBio a priority review voucher after determining its recent approval of Aqneursa (levacetylleucine) qualified ...

latest-news-card-1
Human Drugs

14 Observations in Qualgen FDA-483

FDA releases the form FDA-483 with 14 observations issued following an inspection at the Edmond, OK-based Qualgen outsourcing facility.

latest-news-card-1
Medical Devices

FDA Clears AI-Interpreting Echocardiography Software

FDA clears an iCardio.ai 510(k) for its artificial intelligence software EchoMeasure for interpreting echocardiography.

latest-news-card-1
Human Drugs

Jazz Plans sNDA for Zepzelca in Lung Cancer

Jazz Pharmaceuticals plans to file a supplemental NDA next year following positive top-line results from its Phase 3 clinical trial evaluating Zepzelc...